Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Acta Pharmaceutica Sinica ; (12): 66-71, 2012.
Article in Chinese | WPRIM | ID: wpr-323079

ABSTRACT

An efficient modified route based on the targeting mechanism of antibacterial fluoroquinolones for the shift from the antibacterial activity to the antitumor one was further developed. Using a fused heterocyclic ring, s-triazolothiadiazine as a carboxyl bioisostere of ciprofloxacin, the title compounds, 1-cyclopropyl-6-fluoro-7-piperazin-1-yl-3-(6-substituted-phenyl-7H-[1, 2, 4]triazolo[3, 4-b][1, 3, 4]thiadiazin-3-yl)-quinolin-4(1H)-ones (5a-5e) and their corresponding N-acetyl products (6a-6e), were designed and synthesized, separately. Meaningfully, a ring-contraction of fused six-membered thiadiazine occurred by a sulfur extrusion reaction gave new tri-acetylated fused heterocycles related to pyrazolo[5, 1-c][1, 2, 4] triazoles (7a-7e). The in vitro antitumor activity against L1210, CHO and HL60 cell lines was also evaluated for the synthesized fifteen heterocycles compared to parent ciprofloxacin by methylthiazole trazolium (MTT) assay. Interestingly, the results displayed that fifteen fused heterocyclic compounds showed more significant growth inhibitory activity (IC50 < 25.0 micromo x L(-1)) than that of parent ciprofloxacin (IC50 > 150.0 micromol x L(-1)), and the active order decreased from 7a-7e to 5a-5e to 6a-6e, respective.


Subject(s)
Animals , Cricetinae , Humans , Mice , Antineoplastic Agents , Chemistry , Pharmacology , CHO Cells , Cell Line, Tumor , Ciprofloxacin , Pharmacology , Cricetulus , Fluoroquinolones , Chemistry , Pharmacology , HL-60 Cells , Inhibitory Concentration 50 , Leukemia L1210 , Pathology , Structure-Activity Relationship , Thiadiazines , Chemistry , Pharmacology , Triazoles , Chemistry , Pharmacology
2.
Acta Pharmaceutica Sinica ; (12): 1017-1022, 2012.
Article in English | WPRIM | ID: wpr-276206

ABSTRACT

To explore an efficient strategy for further development of anticancer fluoroquinolone candidates derived from ciprofloxacin, a heterocyclic ring as the bioisosteric replacement of C3 carboxyl group led to a key intermediate, oxadiazole thiol (5), which was further modified to the bis-oxadiazole methylsulfides (7a-7h) and the corresponding dimethylpiperazinium iodides (8a-8h), respectively. Structures were characterized by elemental analysis and spectra data, and their anticancer activities in vitro against CHO, HL60 and L1210 cancer cells were also evaluated by MTT assay. The preliminary results show that piperazinium compounds (8) possess more potent activity than that of corresponding free bases (7).


Subject(s)
Animals , Cricetinae , Humans , Antineoplastic Agents , Chemistry , Pharmacology , CHO Cells , Cell Line, Tumor , Cell Proliferation , Ciprofloxacin , Chemistry , Cricetulus , Drug Design , HL-60 Cells , Inhibitory Concentration 50 , Leukemia L1210 , Molecular Structure , Oxadiazoles , Chemistry , Pharmacology , Piperazines , Chemistry , Pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL